Literature DB >> 19840894

Sensitivity of the female rat to olanzapine-induced weight gain--far from the clinic?

Katrina Weston-Green, Xu-Feng Huang, Chao Deng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19840894     DOI： 10.1016/j.schres.2009.09.034

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  12 in total

1.  Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats.

Authors:  Heidi N Boyda; Ric M Procyshyn; Lurdes Tse; Erin Hawkes; Chen H Jin; Catherine C Y Pang; William G Honer; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

2.  Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.

Authors:  Kieran J Davey; Siobhain M O'Mahony; Harriet Schellekens; Orla O'Sullivan; John Bienenstock; Paul D Cotter; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2012-01-11       Impact factor: 4.530

3.  Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.

Authors:  Ashleigh L Osborne; Nadia Solowij; Ilijana Babic; Xu-Feng Huang; Katrina Weston-Green
Journal:  Neuropsychopharmacology       Date:  2017-02-23       Impact factor: 7.853

4.  Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway.

Authors:  Xue-Mei Liu; Xiao-Min Zhao; Chao Deng; Yan-Ping Zeng; Chang-Hua Hu
Journal:  Acta Pharmacol Sin       Date:  2019-02-06       Impact factor: 6.150

5.  Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats.

Authors:  De-Juan Li; Qin Yue; Lu Liu; Ke-Ke Che; Xue-Mei Liu; Chang-Hua Hu
Journal:  Acta Pharmacol Sin       Date:  2021-05-11       Impact factor: 7.169

Review 6.  Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.

Authors:  Jiezhong Chen; Xu-Feng Huang; Renfu Shao; Chen Chen; Chao Deng
Journal:  Front Neurosci       Date:  2017-11-21       Impact factor: 4.677

7.  Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats.

Authors:  Xuemei Liu; Zhixiang Wu; Jiamei Lian; Chang-Hua Hu; Xu-Feng Huang; Chao Deng
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

8.  Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin.

Authors:  Xuemei Liu; Xiyu Feng; Chao Deng; Lu Liu; Yanping Zeng; Chang-Hua Hu
Journal:  BMC Pharmacol Toxicol       Date:  2020-06-30       Impact factor: 2.483

9.  Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.

Authors:  Heidi N Boyda; Ric M Procyshyn; Catherine C Y Pang; Erin Hawkes; Daniel Wong; Chen Helen Jin; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

10.  Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration.

Authors:  Katrina Weston-Green; Ilijana Babic; Michael de Santis; Bo Pan; Magdalene K Montgomery; Todd Mitchell; Xu-Feng Huang; Jessica Nealon
Journal:  J Biomed Sci       Date:  2018-05-02       Impact factor: 8.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.